WallStSmart

Lesaka Technologies Inc (LSAK)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Lesaka Technologies Inc generates 163% more annual revenue ($680.10M vs $258.90M). LSAK leads profitability with a -7.5% profit margin vs -15.5%. LSAK earns a higher WallStSmart Score of 46/100 (D+).

LSAK

Hold

46

out of 100

Grade: D+

Growth: 6.0Profit: 3.0Value: 8.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.61

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LSAKUndervalued (+87.6%)

Margin of Safety

+87.6%

Fair Value

$37.52

Current Price

$4.77

$32.75 discount

UndervaluedFair: $37.52Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LSAK2 strengths · Avg: 9.0/10
PEG RatioValuation
0.2110/10

Growing faster than its price suggests

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

LSAK4 concerns · Avg: 3.8/10
Revenue GrowthGrowth
1.4%4/10

1.4% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Market CapQuality
$406.14M3/10

Smaller company, higher risk/reward

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : LSAK

The strongest argument for LSAK centers on PEG Ratio, Price/Book. PEG of 0.21 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : LSAK

The primary concerns for LSAK are Revenue Growth, EPS Growth, Altman Z-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

LSAK profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

LSAK scores higher overall (46/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Lesaka Technologies Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

Lesaka Technologies Inc is a pioneering financial technology firm dedicated to reshaping the digital payment landscape across Africa. Utilizing its proprietary platform, the company delivers innovative solutions that enhance transaction efficiency and promote financial inclusion for underserved communities. As a vital participant in the burgeoning digital payment sector within emerging markets, Lesaka is well-positioned to exploit growth opportunities and address key challenges in financial accessibility. With its commitment to market expansion and economic empowerment, Lesaka is set to make a substantial impact on the continent's financial ecosystem.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?